Clinical Trial

HANSE - Holistic Implementation Study Assessing a Northern German Interdisciplinary Lung Cancer Screening Effort

Study acronym: HANSE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The HANSE study is primarily intended as a pilot to provide evidence that a holistic and effective lung cancer screening program can be implemented in Germany and that such a screening program can be integrated in the current infrastructure of certified lung cancer centers.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-05-28; most recent amendment 2025-09-29.
Status change: Recruiting → Active, Not Recruiting 2025-09-29
Status change: Not Yet Recruiting → Recruiting 2021-06-08
Trial Details
NCT Number NCT04913155
Lead Sponsor Hannover Medical School
Collaborators: LungenClinic Grosshansdorf, University Hospital Schleswig-Holstein, German Center for Lung Research
Conditions Lung Cancer
Enrollment 12,100 participants
Start Date 2021-05-20
Primary Completion 2024-03-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-03